Home/Dangerous Drugs
Jan 11, 2019

Former CEO of Insys to Plead Guilty in Opioid-Kickback Scheme

By |Jan 11, 2019|Dangerous Drugs|0 Comments

In late December of 2018, federal prosecutors announced that Michael Babich, former CEO of Insys Therapeutics, agreed to plead guilty to participating in a bribery scheme which gave kickbacks to doctors in exchange for prescribing a powerful opioid painkiller. Babich, who resigned his role as CEO of the Arizona-based drug manufacturing firm, was scheduled to [...]

Sep 18, 2018

Januvia and Byetta Lawsuits Are Going Back to Court

By |Sep 18, 2018|Dangerous Drugs|0 Comments

Januvia and Byetta, along with Janumet and Victoza, are the diabetes drugs at the center of 945 lawsuits. The cases had originally been dismissed, but a federal appeals court overturned that decision in December of 2017, and remanded the cases back to U.S. District Judge Anthony Battaglia in the Southern District of California. He has [...]

Jun 27, 2018

Opioid Antidote Naloxone Recalled by Manufacturer

By |Jun 27, 2018|Dangerous Drugs|0 Comments

Drug manufacturer Hospira has recalled Naloxone, the medication commonly used by first responders, medical professionals, and hospitals to quickly reverse suspected conditions of an opioid overdose. The National Institute on Drug Abuse states that Naloxone works as an opioid antagonist, attaching to opioid receptors in the brain. Therefore, when it is administered to a drug [...]

Jun 20, 2018

Voluntary Withdrawal of Zinbryta from the Market After Concerns Arise Over Liver and Brain Damage

By |Jun 20, 2018|Dangerous Drugs|0 Comments

The drug Zinbryta has been recalled on a voluntary basis by its manufacturers according to the recommendation of the European Medicines Agency (EMA) in cooperation with the Food & Drug Administration (FDA). Zinbryta (daclizumab) was approved by the FDA in May 2016 for the treatment of individuals suffering from various relapses of multiple sclerosis (MS). [...]

Jun 14, 2018

Ocaliva Dosage Errors Prompt the FDA to Require New Black Box Warning

By |Jun 14, 2018|Dangerous Drugs|0 Comments

FDA officials have now added a boxed warning label to obeticholic acid (Ocaliva), a liver disease medicine, in order to emphasize the proper dosing patients with rare chronic liver disease should follow. The FDA announcement states that the designated daily dosage for obeticholic acid, manufactured by Intercept Pharmaceuticals, has been incorrect. Instead, the dosage has [...]

Jun 12, 2018

Nuplazid Produced Worsening Conditions for Many Users

By |Jun 12, 2018|Dangerous Drugs|0 Comments

Anti-psychotic drug Nuplazid (pimavanserin) is manufactured by Acadia pharmaceuticals and approved by the Federal Drug Administration (FDA) for treating Parkinson’s disease patients with debilitating psychosis. The process of approval used for Nuplazid allowed an expedited pharmaceutical safety review by categorizing this drug as a breakthrough therapy. Instituted by Congress in 2012, this breakthrough therapy classification [...]

Jun 4, 2018

Warning: These Teething Medicines Are Unsafe for Your Baby

By |Jun 4, 2018|Dangerous Drugs|0 Comments

The U.S. Food and Drug Administration (FDA) is warning consumers about an over-the-counter teething medication for infants and children under the age of two that could be harmful. The agency says that products containing benzocaine are dangerous and pose a serious risk to infants and children under two. Benzocaine is used to treat sore gums, [...]

May 24, 2018

Several Diabetes Drugs May Cause Increased Risk of Toe Amputation

By |May 24, 2018|Dangerous Drugs|0 Comments

Recent findings provided by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) detail the connection between the use of several diabetes drugs and the elevated risk of toe amputation. The diabetes drugs that pose this serious risk to patients are classified as sodium-glucose cotransporter-2 (SGLT2) inhibitors used to treat individuals with [...]

May 15, 2018

Man Loses His Lower Right Leg After Using Invokana Diabetes Drug

By |May 15, 2018|Dangerous Drugs|0 Comments

Michael R. Wilkinson was prescribed Invokana (otherwise referred to as canagliflozin) in order to help manage his diabetic condition. He began taking the drug in April 2015. By December that same year, he was forced to undergo an amputation of his right leg below the knee. Unaware of the possible connection between his use of [...]

May 3, 2018

Concerns about Invokana and Lower Limb Amputation Risks

By |May 3, 2018|Dangerous Drugs|0 Comments

The drug Invokana, also referred to as canagliflozin, is used to treat patients for Type 2 diabetes. Invokana first entered the market in 2013. Since then it has become one of the most widely used diabetes medications in the U.S. Alarmingly, the drug has been linked to a number of difference serious side effects and [...]

Free Case Evaluation

No-Obligation Case Review:

  • How do you prefer that we contact you? *
  • This field is for validation purposes and should be left unchanged.

South Carolina Injury Attorneys

Our Testimonials

“Worked hard all the way through trial, got a good result and got to know me and my family on a personal level, treating us like friends and not simply clients” — Melissa Phillips

“I tried to handle my legal problem without help. I was getting nowhere when I contacted Patrick Killen at McGowan Hood. After asking me some questions, Patrick came up with a plan to solve my problem.He kept me informed during the case and made the process easy for me. Patrick got great results for me that were a lot better than I expected.”    — Michael Graham., Columbia, SC

“I am extremely happy with the way my lawsuit was handled. McGowan Hood went over and beyond to help my son and me. I was more than happy with the result and  would like to thank them from the highest.” — Carrie White

TEXT USCALL US